Clinical Trial Update: A Phase 1b/2a, Study Evaluating the Safety, PK/PD and Efficacy of NS101 in Healthy Volunteers and SSNHL Patients [Phase 1, Phase 2]

View source ↗

Summary

Phase 1b/2a clinical trial evaluating NS101 in healthy volunteers and patients with sudden sensorineural hearing loss; currently recruiting to assess safety, PK…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sensorineural Hearing Loss
• Sudden Sensorineural Hearing Loss

Drugs mentioned

• NS101

Snippet

Sponsor: Neuracle Science Co., LTD. | Conditions: Seneorineural Deafness, Sudden Sensorineural Hearing Loss | Phase 1, Phase 2 | Status: RECRUITING